[HTML][HTML] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - …, 2016 - mdanderson.elsevierpure.com
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
[PDF][PDF] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - pdfs.semanticscholar.org
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - Oncotarget, 2016 - europepmc.org
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
[PDF][PDF] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - academia.edu
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
[HTML][HTML] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - Oncotarget, 2016 - oncotarget.com
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer |
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
[PDF][PDF] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - researchgate.net
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
[引用][C] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - Oncotarget, 2016 - cir.nii.ac.jp
NFIB overexpression cooperates with <i>Rb/p53</i> deletion to promote small cell lung cancer
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor type that is
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
typically metastatic upon diagnosis. We have a poor understanding of the factors that control …
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
N Wu, D Jia, AH Ibrahim, CJ Bachurski… - Oncotarget, 2016 - oncotarget.com
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer |
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …